Literature DB >> 4827367

Phosphoglycerate mutase isozyme marker for tissue differentiation in man.

G S Omenn, S C Cheung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4827367      PMCID： PMC1762627     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  14 in total

1.  Resurgence of two fetal-type of aldolases (A and C) in some fast-growing hepatomas.

Authors:  F Schapira; M D Reuber; A Hatzfeld
Journal:  Biochem Biophys Res Commun       Date:  1970-07-27       Impact factor: 3.575

Review 2.  Clinical and laboratory studies of ectopic humoral syndromes.

Authors:  G W Liddle; W E Nicholson; D P Island; D N Orth; K Abe; S C Lowder
Journal:  Recent Prog Horm Res       Date:  1969

3.  The effects of mercury and other reagents on phosphoglycerate mutase-2,3-diphosphoglycerate phosphatase from kidney, muscle and other tissues.

Authors:  D Diederich; A Khan; I Santos; S Grisolia
Journal:  Biochim Biophys Acta       Date:  1970-09-16

4.  Ectopic production of an alkaline phosphatase isoenzyme in patients with cancer.

Authors:  L L Stolbach; M J Krant; W H Fishman
Journal:  N Engl J Med       Date:  1969-10-02       Impact factor: 91.245

5.  Purification and properties of phosphoglyceromutase from sheep muscle.

Authors:  E James; R O Hurst; T G Flynn
Journal:  Can J Biochem       Date:  1971-11

6.  Ectopic polypeptide hormone production by tumors.

Authors:  G S Omenn
Journal:  Ann Intern Med       Date:  1970-01       Impact factor: 25.391

7.  Aldolase isozyme patterns of representative tumours in the human nervous system.

Authors:  T Kumanishi; F Ikuta; T Yamamoto
Journal:  Acta Neuropathol       Date:  1970       Impact factor: 17.088

8.  Evidence for a phosphohistidine protein intermediate in the phosphoglycerate mutase reaction.

Authors:  Z B Rose
Journal:  Arch Biochem Biophys       Date:  1970-10       Impact factor: 4.013

9.  Developmental increases in activity and sensitivity to mercury of human and chicken skeletal muscle phosphoglycermutase.

Authors:  J Grisolia; D Diederich; S Grisolia
Journal:  Biochem Biophys Res Commun       Date:  1970-12-09       Impact factor: 3.575

10.  The purification and properties of phosphoglycerate mutase from chicken breast muscle.

Authors:  A Torralba; S Grisolia
Journal:  J Biol Chem       Date:  1966-04-25       Impact factor: 5.157
View more
  11 in total

1.  A single MEF-2 site is a major positive regulatory element required for transcription of the muscle-specific subunit of the human phosphoglycerate mutase gene in skeletal and cardiac muscle cells.

Authors:  Y Nakatsuji; K Hidaka; S Tsujino; Y Yamamoto; T Mukai; T Yanagihara; T Kishimoto; S Sakoda
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

2.  Inactivation of phosphoglycerate mutase and creatine kinase isoenzymes in human serum.

Authors:  N Durany; J Carreras; M Valentí; J Cámara; J Carreras
Journal:  Mol Pathol       Date:  2002-08

3.  Activity of phosphoglycerate mutase and its isoenzymes in serum after acute myocardial infarction.

Authors:  N Durany; E Carballo; J Joseph; J L Bedini; R Bartrons; A M Ballesta; J Carreras
Journal:  Clin Mol Pathol       Date:  1996-10

4.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas.

Authors:  N Durany; J Joseph; E Campo; R Molina; J Carreras
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 5.  GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  Cytokine Growth Factor Rev       Date:  2016-09-15       Impact factor: 7.638

6.  Structure, expression and duplication of genes which encode phosphoglyceromutase of Drosophila melanogaster.

Authors:  P D Currie; D T Sullivan
Journal:  Genetics       Date:  1994-10       Impact factor: 4.562

7.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma.

Authors:  N Durany; J Joseph; O M Jimenez; F Climent; P L Fernández; F Rivera; J Carreras
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

8.  Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis.

Authors:  Qian Sun; Shuzhan Li; Yanan Wang; Haiyong Peng; Xiying Zhang; Yu Zheng; Chunjia Li; Li Li; Rongrong Chen; Xinxin Chen; Wenjing Bai; Xiangli Jiang; Liang Liu; Feng Wei; Boshi Wang; Yu Zhang; Hui Li; Xiubao Ren; Hongbing Zhang
Journal:  Cell Death Differ       Date:  2018-01-23       Impact factor: 15.828

Review 9.  Phosphoglycerate Mutase 1: Its Glycolytic and Non-Glycolytic Roles in Tumor Malignant Behaviors and Potential Therapeutic Significance.

Authors:  Na Li; Xinlu Liu
Journal:  Onco Targets Ther       Date:  2020-02-27       Impact factor: 4.147

10.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and creatine kinase activity and isoenzymes in human brain tumours.

Authors:  N Durany; J Joseph; F F Cruz-Sánchez; J Carreras
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.